Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 753-759

  Pereira, H Anne ^a,b   Kumar, Padmasini ^a   Grammas, Paula ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b BMSB 434 ^*  (United States)

Author keywords

Alzheimer's disease; CAP37; Chemoattractant; Inflammation; Vascular endothelium; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CATIONIC ANTIMICROBIAL PROTEIN M; CHEMOTACTIC FACTOR; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030250384     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(96)00118-2     Document Type: Article

References (51)

1. 1. Araujo, D.M.; Cotman, C. W. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569:141-145; 1992.
2. 2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett. 285:111-114; 1991.
3. 3. Bauer, J.; Strauss, S.; Volk, B.; Berger, M. Interleukin-6-mediated events in Alzheimer's Disease pathology. Immunol. Today 12:422; 1991.
4. 4. Bevilacqua, M. P.; Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767-804; 1993.
5. 5. Breitner, J. C. S.; Gau, B. A.; Welsh, K. A.; Plassman, B. L.; McDonald. W. M.; Helms, M. J.; Anthony, J. C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-232; 1994.
6. 6. Corder, E. H.; Saunders, A. M.; Strictmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; Roses, A. D.; Haines, J. L.; Pericak-Vance, M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923; 1993.
7. 7. Del Bo, R.; Angeretti, N.; Lucca, E.; DeSimoni, M. G.; Forloni, G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6 and β-amyloid production in cultures. Neurosci. Lett. 188:70-74; 1995.
8. 8. Dickson, D. W.; Lee, S. C.; Mattiace, L. A.; Yen, S.-H. C.; Brosnan, C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83; 1993.
9. 9. Diglio, C. A.; Liu. W.; Grammas, P.; Giacomelli, F.; Wiener, J. Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue Cell 25:833-846; 1993.
10. 10. Eikelenboom, P.; Hack, C. E.; Rozemuller, J. M.; Stam, F. C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B Cell Pathol. 56:259-262; 1989.
11. 11. Eikelenboom, P.; Rozemuller, J. M.; Kraal, G.; Stam, F. C.; McBride. P. A.; Bruce, M. E.; Fraser, H. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch. B Cell Pathol. 60:329-336; 1991.
12. 12. Flodgaard, H.; Ostergaard, E.; Bayne, S.; Svendsen, A.; Thomsen, J.; Engels, M.; Wollmer, A. A covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocytes and fibroblast chemotactic activities. Eur. J. Biochem. 197:535-547; 1991.
13. 13. Frangione, B.; Wisniewski, T.; Ghiso, J. Chaperoning Alzheimer's amyloids. Neurobiol. Aging 15:S97-S100; 1994.
14. 14. Frohman, E. M.; Frohman, T. C.; Sudhir, G.; de Fougerolles, A.; van den Noort, S. Expression of intercellular adhesion molecule I (ICAM-1) in Alzheimer's disease. J. Neurol. Sci. 106:105-111; 1991.
15. 15. Goldgaber D.; Harris, H. W.; Hia, T.; Maciag, T.; Donnelly, R. J.; Jacobsen, J. S.; Vitek, M. P.; Gajdusek, D. C. Interleukin-1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cell. Proc. Natl. Acad. Sci. USA 86:7606-7610; 1989.
16. 16. Huell, M.; Strauss, S.; Volk, B.; Berger, M.; Bauer, J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. 89:544-551; 1995.
17. 17. Ishii, T., Haga, S. Complements, microglial cells and amyloid fibril formation. Res. Immunol. 143:614-616; 1992.
18. 18. Krzanowski, J. J. Microglia and immune activation in Alzheimer's disease. J. Florida Med. Assoc. 80:267-270; 1993.
19. 19. Lucca, U.; Tettamanti, M.; Forloni, G.; Spagnoli, A. Nonsteroidal anti-inflammatory drug use in Alzheimer's disease. Soc. Biol. Psychiatry 36:854-856; 1994.
20. 20. Mattiace, L. A.; Davies, P.; Yen, S.-H.; Dickson, D. W. Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol. 80:493-498; 1990.
21. 21. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:516-527; 1989.
22. 22. McGeer, P. L.; McGeer, E.; Rogers, J.; Sibley, J. Anti-inflammatory drugs and Alzheimer's disease. Lancet 335:1037; 1990.
23. 23. McGeer, P. L.; Akiyama, H.; Kawamata, T.; Yamada, T.; Walker, D. G.; Ishii, T. Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J. Neurosci. Res. 31:428-442; 1992.
24. 24. McGeer, P. L., Rogers, J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42:447-449; 1992.
25. 25. Mirra, S, S.; Hart, M. N.; Terty, R. D. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch. Pathol. Lab Med. 117:132-144; 1993.
26. 26. Morgan, J. G.; Sukiennicki, T.; Pereira, H. A.; Spitznagel, J. K.; Guerra, M. E.; Larrick, J. W. Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J. Immunol. 147:3210-3214; 1991.
27. 27. Morgan, J. G.; Pereira, H. A.; Sukiennicki, T.; Spitznagel, J.K.; Larrick, J. W. Human neutrophil granule cationic protein, CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv. Exp. Med. Biol. 305:89-96; 1991.
28. 28. Ohyagi, Y.; Tabira, T. Effect of growth factors and cytokines on expression of amyloid β protein precursor mRNAs in cultured neural cells. Mol. Brain Res. 18:127-132; 1993.
29. 29. Ostergaard, E.; Flodgaard, H. A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion. J. Leukoc. Biol. 51:316-323; 1992.
30. 30. Pereira, H. A. CAP37, a neutrophil-derived multifunctional inflammatory mediator. J. Leukoc. Biol. 57:805-812; 1995.
31. 31. Pereira, H. A.; Martin, L. E.: Spitznagel, J. K. Quantitation of a cationic antimicrobial granule protein of human polymorphonuclear leukocytes by ELISA. J. Immunol. Methods 117:115-120; 1989.
32. 32. Pereira, H. A.; Shafer, W. M.; Pohl, J.; Martin, L. E.; Spitznagel, J. K. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest. 85:1468-1476; 1990.
33. 33. Pereira, H. A.; Spitznagel, J. K.; Pohl, J.: Wilson, D. E.; Morgan, J.; Palings, I.; Larrick, J. W. CAP37, A 37 kd human neutrophil granule cationic protein shares homology with inflammatory proteinases. Life Sci. 46:189-196; 1990.
34. 34. Pereira, H. A.; Erdem, I.; Pohl, J.; Spitznagel, J. K. Synthetic bactericidal peptide based on CAP37: A 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc. Natl. Acad. Sci. USA 90:4733-4737; 1993.
35. 35. Pereira, H. A.; Lacquement, M. CAP37, a monocyte chemoattractant induces superoxide production. J. Free Radic. Biol. Med. 2:P1; 1994.
36. 36. Pereira, H. A.; Moore, P.; Grammas, P. CAP37, a neutrophil granule-derived protein stimulates protein kinase C activity in endothelial cells. J. Leukoc. Biol. (in press).
37. 37. Perlmutter, L. S.; Scott, S.A.; Barron. E.; Chui, H. C. MHC class H-positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 33:549-558; 1992.
38. 38. Peterson, L. C.; Birktoft, J. J.; Flodgaard, H. Binding of bovine pancreatic trypsin inhibitor to heparin binding protein/CAP37/azurocidin-Interaction between a Kunitz-type inhibitor and a proteolytically inactive serine proteinase homologue. Eur. J. Biochem. 214:271-279; 1993.
39. 39. Pohl, J.; Pereira, H. A.; Martin, N. M.; Spitznagel, J. K. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett. 272:200-204; 1990.
40. 40. Rich, J. B.; Rasmusson, D. X.; Folstein, M. F.; Carson, K. A.; Kawas, C.; Brandt. J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-55; 1995.
41. 41. Rothwell, N. J.; Strijbos, P. J. L. M. Cytokines in neurodegeneration and repair. Int. J. Devl. Neurosci. 13:179-185; 1995.
42. 42. Rothwell, N.J.; Hopkins, S. J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18:130-136: 1995.
43. 43. Rozemuller, J. M.; Eikelenboom, P.; Pals. S. T.; Stam, E. C. Microglial cells around amyloid plaques in Alzheimer's disease express leukocyte adhesion molecules of the LFA-I family. Neurosci. Lett. 101: 288-292; 1989.
44. 44. Schnabel, J. New Alzheimer's therapy suggested. Science 260:1719-1720; 1993.
45. 45. Selkoe, D. J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:489-517; 1994.
46. 46. Selkoe, D. J. Alzheimer's disease: A central role for amyloid. J. Neuropathol. Exp. Neurol. 53:438-447; 1994.
47. 47. Shafer, W. M.; Martin, L. E.; Spitznagel, J. K. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect. Immun. 45:29-35; 1984.
48. 48. Shalit F.; Sredni, B.; Stem, L.; Kott, E.; Huberman, M. Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci. Lett 174:130-132; 1994.
49. 49. Strittmater, W. J.; Weisgraber, K. H.; Huang, D. Y.; Dong, L. M.; Salvesen, G. S.; Pericak-Vance, M.; Schmechel D.; Saunders, A. M.; Goldgaber, D.; Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:8098-8102; 1993.
50. 50. Vandenabeele, P.; Fiers, W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated "acute phase response" in the brain? Immunol. Today 12:217-219; 1991.
51. 51. Walker, D. G.; Kim, S. U.; McGeer, P. L. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40:478-493; 1995.